ISPOR Code of Ethics 2017 (4th Edition)

被引:9
|
作者
Santos, Jessica [1 ]
Palumbo, Francis [2 ]
Molsen-David, Elizabeth [3 ]
Willke, Richard J. [4 ]
Binder, Louise [5 ]
Drummond, Michael [6 ,7 ]
Ho, Anita [8 ]
Marder, William D. [9 ]
Parmenter, Louis [10 ]
Sandhu, Gurmit [11 ]
Shafie, Asrul A. [12 ,13 ,14 ]
Thompson, David [15 ,16 ]
机构
[1] Kantar Hlth, Cambridge, Wales
[2] Univ Maryland, Sch Pharm, Ctr Drugs & Publ Policy, Bethesda, MD 20814 USA
[3] ISPOR, Sci & Hlth Policy Initiat, Lawrenceville, NJ USA
[4] ISPOR, Lawrenceville, NJ USA
[5] Save Your Skin Fdn, Toronto, ON, Canada
[6] Univ York, Ctr Hlth Econ, Value Hlth, York, N Yorkshire, England
[7] Univ York, Ctr Hlth Econ, Hlth Econ, York, N Yorkshire, England
[8] Natl Univ Singapore, Ctr Biomed Eth, Undergrad Med Eth Curriculum, Singapore, Singapore
[9] IBM Watson Hlth, Cambridge, MA USA
[10] QuintilesIMS, Global Head Sci Affairs, Reading, Berks, England
[11] Gurmit Sandhu Consulting GmbH, Basel, Switzerland
[12] Univ Sains Malaysia, Minden, Malaysia
[13] Natl Good Governance Med Policy, Minden, Malaysia
[14] Eth Board Malaysia, Minden, Malaysia
[15] INC Res InVentiv Hlth, Value & Outcomes Spotlight, Boston, MA USA
[16] INC Res InVentiv Hlth, Real World Evidence Advisory, Boston, MA USA
关键词
EMERGING GOOD PRACTICES; TASK-FORCE; HEALTH; PATIENT; RECOMMENDATIONS;
D O I
10.1016/j.jval.2017.10.018
中图分类号
F [经济];
学科分类号
02 ;
摘要
As the leading health economics and outcomes research (HEOR) professional society, ISPOR has a responsibility to establish a uniform, harmonized international code for ethical conduct. ISPOR has updated its 2008 Code of Ethics to reflect the current research environment. This code addresses what is acceptable and unacceptable in research, from inception to the dissemination of its results. There are nine chapters: 1 - Introduction; 2 - Ethical Principles respect, beneficence and justice with reference to a non-exhaustive compilation of international, regional, and country-specific guidelines and standards; 3 - Scope HEOR definitions and how HEOR and the Code relate to other research fields; 4 - Research Design Considerations primary and secondary data related issues, e.g., participant recruitment, population and research setting, sample size/site selection, incentive/honorarium, administration databases, registration of retrospective observational studies and modeling studies; 5 - Data Considerations privacy and data protection, combining, verification and transparency of research data, scientific misconduct, etc.; 6 - Sponsorship and Relationships with Others (roles of researchers, sponsors, key opinion leaders and advisory board members, research participants and institutional review boards (IRBs) / independent ethics committees (IECs) approval and responsibilities); 7 - Patient Centricity and Patient Engagement new addition, with explanation and guidance; 8 - Publication and Dissemination; and 9 - Conclusion and Limitations. Copyright (C) 2017, International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc.
引用
收藏
页码:1227 / 1242
页数:16
相关论文
共 50 条